This website is intended for healthcare professionals (HCPs) only. We hope that you
find the content on this website useful to your clinical practice.
iMCD is a very heterogenous disease and there is no typical patient. Uncontrolled iMCD can lead to severe organ damage, increased risk of developing cancers and death1
References
1. Liu AY et al. The Lancet Haematology 2016
2. Fajgenbaum DC et al. Blood 2017; 129(12): 1646-1657